10-K Decoder · All companies

10x Genomics, Inc.

TXG · FY2025 · Fiscal year ended Dec 31, 2025 · 10-K filed Feb 2026

Open the dashboardInfographicSummary

FY2025 key figures

$FY2025FY2024Change
Revenue$643M$611M+5.2%
Operating income−$61.0M−$195M+68.7%
Net income−$43.5M−$183M+76.2%

Latest quarter: Q3 2026

Form 10-Q · Three months ended Sep 30, 2026 · filed Nov 6, 2026

$Q3 2026Year earlierChange
Revenue$151M$149M+1.1%
Operating income−$16.1M−$32.2M+50.0%
Net income−$19.4M−$27.5M+29.5%

Q3 2026 dashboardQ3 2026 infographic

Questions

What was 10x Genomics's revenue in FY2025?
$643M in FY2025 (Fiscal year ended Dec 31, 2025), +5.2% vs $611M a year earlier, per its 10-K filed Feb 2026.
Was 10x Genomics profitable in FY2025?
No: net income was −$43.5M and operating income −$61.0M in FY2025.
What was 10x Genomics's revenue in Q3 2026?
$151M (+1.1% vs a year earlier), per its Form 10-Q filed Nov 6, 2026.